Clinical Trial Update: Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating conversion of hyperglycemic patients receiving intravenous insulin infusions to Lantus insulin (insulin glargine).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hyperglycemia

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Northwestern University | Conditions: Hyperglycemia, Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2009-04-06